Researchers Find More Clues To Causes Of Breast Cancer
Thursday, October 27, 2011 - 11:01
in Health & Medicine
Publishing in the current issue of The Journal of Biological Chemistry, Moffitt Cancer Center researchers have discovered additional mechanisms of "Akt" activation and suggest a component of that activation mechanism - inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) - could be targeted as a therapeutic intervention for treating cancer.